Article Text
Abstract
Although informed consent models for prescribing hormone replacement therapy are becoming increasingly prevalent, many physicians continue to require an assessment and referral letter from a mental health professional prior to prescription. Drawing on personal and communal experience, the author argues that assessment and referral requirements are dehumanising and unethical, foregrounding the ways in which these requirements evidence a mistrust of trans people, suppress the diversity of their experiences and sustain an unjustified double standard in contrast to other forms of clinical care. Physicians should abandon this unethical requirement in favour of an informed consent approach to transgender care.
- clinical ethics
- minorities
- sexuality/gender
- feminism
Statistics from Altmetric.com
Footnotes
Contributors FA is the sole contributor.
Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Patient consent for publication Not required.
Other content recommended for you
- Integrity and rights to gender-affirming healthcare
- Responding to objections to gatekeeping for hormone replacement therapy
- Reply to ‘Hormone replacement therapy: informed consent without assessment?’
- Hormone replacement therapy: informed consent without assessment?
- Assessment and support of children and adolescents with gender dysphoria
- Sex and gender terminology: a glossary for gender-inclusive epidemiology
- Two dilemmas for medical ethics in the treatment of gender dysphoria in youth
- What are the health outcomes of trans and gender diverse young people in Australia? Study protocol for the Trans20 longitudinal cohort study
- Current management of male-to-female gender identity disorder in the UK
- Safeguarding LGBT+ adolescents